CBCT-based adaptive radiotherapy and automated radiotherapy decision-making systems: development and current status
- 1Department of Radiation Oncology, Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University , , ,
Abstract
Cone-beam computed tomography (CBCT)-based adaptive radiotherapy (ART) has emerged as a promising strategy for addressing inter-fractional anatomical and physiological changes during treatment. By incorporating on-treatment imaging, ART enables treatment plans to be adapted to the anatomy of the day, with the potential to improve target coverage and reduce dose exposure to organs at risk (OARs). However, routine implementation remains constrained by the limited image quality of CBCT, uncertainties in dose calculation, labour-intensive workflows and the lack of reliable criteria for determining when adaptation is clinically necessary. This review summarises the development, current status and future prospects of CBCT-based ART, with particular emphasis on artificial intelligence (AI)-assisted automated delineation and automated radiotherapy decision-making systems. CBCT is widely available on modern linear accelerators and remains the most practical imaging basis for ART in many centres. Nevertheless, poor soft-tissue contrast, noise, artefacts, field-of-view truncation and unstable Hounsfield unit values limit its performance in target delineation and dose reconstruction. Recent advances in image-quality enhancement, deformable image registration and synthetic CT generation have partially addressed these limitations. AI-based auto-segmentation models, including convolutional neural networks, Transformers, generative adversarial networks and diffusion models, have demonstrated increasingly favourable geometric accuracy and workflow efficiency. Automated decision-making systems can advise clinicians whether treatment-plan adaptation is required and how it should be implemented according to each patient’s circumstances, representing a prerequisite for more efficient ART. Current research has mainly focused on two approaches: adaptation triggered by predefined dosimetric thresholds, and artificial-intelligence-based models that learn from prior knowledge and predict potential dosimetric changes for the current patient based on previous experience. Both approaches have their respective strengths and limitations, but require further refinement, including the systematic exploration of decision thresholds. Moreover, the realisation of fully automated adaptive radiotherapy will require the integration of additional systems, including automated treatment planning and automated QA. Overall, CBCT-based ART assisted by AI is technically feasible and may improve dosimetric quality and treatment efficiency. Future progress requires improved CBCT-specific algorithms, integrated automated planning and QA, multicentre validation, standardised safety frameworks and stronger evidence of clinical benefit.
Related
- Automated Radiotherapy Planning for Head-and-neck Cancer: Multi-institutional Development, Validation, and Clinical Implementation of Monaco Scripting
- Development of a phantom‐based end‐to‐end QA workflow for online adaptive radiotherapy incorporating high‐resolution 2D detector measurements
- Cone-beam CT-based synthetic CT generation for adaptive radiotherapy: methodological paradigms, clinical reliability assessment, and translation
- CBCT-Guided Online Adaptive Ultrahypofractionated Whole-Breast Radiotherapy for Early-Stage Breast Cancer: Dosimetric Outcomes and Acute Toxicity.
- A digital-twin framework for forecasting treatment-day imaging with contour uncertainty in adaptive proton radiotherapy
BibTeX
@article{wang2026cbctbased,
title = {{CBCT-based adaptive radiotherapy and automated radiotherapy decision-making systems: development and current status}},
author = {Shang Wang and Xin Wang},
journal = {Frontiers in oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1957030},
url = {https://europepmc.org/article/PMC/PMC13673412},
note = {CC BY},
}
RIS
TY - JOUR
TI - CBCT-based adaptive radiotherapy and automated radiotherapy decision-making systems: development and current status
AU - Shang Wang
AU - Xin Wang
PY - 2026
DA - 2026/10/02
JO - Frontiers in oncology
DO - 10.3389/fonc.2026.1957030
UR - https://europepmc.org/article/PMC/PMC13673412
AB - Cone-beam computed tomography (CBCT)-based adaptive radiotherapy (ART) has emerged as a promising strategy for addressing inter-fractional anatomical and physiological changes during treatment. By incorporating on-treatment imaging, ART enables treatment plans to be adapted to the anatomy of the day, with the potential to improve target coverage and reduce dose exposure to organs at risk (OARs). However, routine implementation remains constrained by the limited image quality of CBCT, uncertainties in dose calculation, labour-intensive workflows and the lack of reliable criteria for determining when adaptation is clinically necessary. This review summarises the development, current status and future prospects of CBCT-based ART, with particular emphasis on artificial intelligence (AI)-assisted automated delineation and automated radiotherapy decision-making systems. CBCT is widely available on modern linear accelerators and remains the most practical imaging basis for ART in many centres. Nevertheless, poor soft-tissue contrast, noise, artefacts, field-of-view truncation and unstable Hounsfield unit values limit its performance in target delineation and dose reconstruction. Recent advances in image-quality enhancement, deformable image registration and synthetic CT generation have partially addressed these limitations. AI-based auto-segmentation models, including convolutional neural networks, Transformers, generative adversarial networks and diffusion models, have demonstrated increasingly favourable geometric accuracy and workflow efficiency. Automated decision-making systems can advise clinicians whether treatment-plan adaptation is required and how it should be implemented according to each patient’s circumstances, representing a prerequisite for more efficient ART. Current research has mainly focused on two approaches: adaptation triggered by predefined dosimetric thresholds, and artificial-intelligence-based models that learn from prior knowledge and predict potential dosimetric changes for the current patient based on previous experience. Both approaches have their respective strengths and limitations, but require further refinement, including the systematic exploration of decision thresholds. Moreover, the realisation of fully automated adaptive radiotherapy will require the integration of additional systems, including automated treatment planning and automated QA. Overall, CBCT-based ART assisted by AI is technically feasible and may improve dosimetric quality and treatment efficiency. Future progress requires improved CBCT-specific algorithms, integrated automated planning and QA, multicentre validation, standardised safety frameworks and stronger evidence of clinical benefit.
SN - 2234-943X
ER -